SIRT5 downregulation is associated with poor prognosis in glioblastoma.

CONCLUSIONS: Collectively, our results indicate that SIRT5 acts as a potential suppresser during tumorigenesis, and suggest that SIRT5 may be a promising prognostic biomarker of GBM.
PMID: 30909186 [PubMed - as supplied by publisher]

Source: Cancer Biomarkers : Section A of Disease Markers - March 14, 2019 Category: Cancer & Oncology Authors: Chen X, Xu Z, Zeng S, Wang X, Liu W, Qian L, Wei J, Yang X, Shen Q, Gong Z, Yan Y Tags: Cancer Biomark Source Type: research